vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SEMrush Holdings, Inc.（SEMR）财务数据对比。点击上方公司名可切换其他公司
SEMrush Holdings, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$117.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 14.6%），SEMrush Holdings, Inc.自由现金流更多（$14.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 17.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
SEMrush Holdings, Inc.是美国上市企业，旗下SaaS平台Semrush是知名的数字营销分析工具，可用于关键词研究、竞品分析、站点审计、反向链接追踪、域名权重监测及线上曝光度分析，能为每个关键词提供多维度数据，平台数据来自谷歌、必应等搜索引擎，可助力企业优化线上营销策略，提升数字运营效率。
PBYI vs SEMR — 直观对比
营收规模更大
SEMR
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出13.1%
14.6%
自由现金流更多
SEMR
多$446.0K
$14.4M
两年增速更快
PBYI
近两年复合增速
17.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $117.7M |
| 净利润 | — | $-11.1M |
| 毛利率 | 69.3% | 80.4% |
| 营业利润率 | 22.7% | -11.8% |
| 净利率 | — | -9.4% |
| 营收同比 | 27.7% | 14.6% |
| 净利润同比 | — | -431.8% |
| 每股收益（稀释后） | $0.26 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISEMR
| Q4 25 | $75.5M | $117.7M | ||
| Q3 25 | $54.5M | $112.1M | ||
| Q2 25 | $52.4M | $108.9M | ||
| Q1 25 | $46.0M | $105.0M | ||
| Q4 24 | $59.1M | $102.6M | ||
| Q3 24 | $80.5M | $97.4M | ||
| Q2 24 | $47.1M | $91.0M | ||
| Q1 24 | $43.8M | $85.8M |
净利润PBYISEMR
| Q4 25 | — | $-11.1M | ||
| Q3 25 | $8.8M | $-2.1M | ||
| Q2 25 | $5.9M | $-6.6M | ||
| Q1 25 | $3.0M | $849.0K | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $20.3M | $1.1M | ||
| Q2 24 | $-4.5M | $1.7M | ||
| Q1 24 | $-4.8M | $2.1M |
毛利率PBYISEMR
| Q4 25 | 69.3% | 80.4% | ||
| Q3 25 | 77.7% | 80.2% | ||
| Q2 25 | 76.5% | 80.6% | ||
| Q1 25 | 77.1% | 81.1% | ||
| Q4 24 | 76.4% | 81.7% | ||
| Q3 24 | 63.9% | 82.5% | ||
| Q2 24 | 77.4% | 83.6% | ||
| Q1 24 | 75.5% | 82.9% |
营业利润率PBYISEMR
| Q4 25 | 22.7% | -11.8% | ||
| Q3 25 | 17.6% | -4.0% | ||
| Q2 25 | 12.7% | -4.0% | ||
| Q1 25 | 8.7% | -0.1% | ||
| Q4 24 | 22.6% | 1.7% | ||
| Q3 24 | 27.4% | 1.8% | ||
| Q2 24 | -4.6% | 3.7% | ||
| Q1 24 | -5.3% | 1.7% |
净利率PBYISEMR
| Q4 25 | — | -9.4% | ||
| Q3 25 | 16.2% | -1.9% | ||
| Q2 25 | 11.2% | -6.0% | ||
| Q1 25 | 6.5% | 0.8% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 25.2% | 1.1% | ||
| Q2 24 | -9.6% | 1.8% | ||
| Q1 24 | -11.0% | 2.5% |
每股收益（稀释后）PBYISEMR
| Q4 25 | $0.26 | $-0.09 | ||
| Q3 25 | $0.17 | $-0.01 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $0.06 | $0.01 | ||
| Q4 24 | $0.40 | $0.03 | ||
| Q3 24 | $0.41 | $0.01 | ||
| Q2 24 | $-0.09 | $0.01 | ||
| Q1 24 | $-0.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $264.3M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $288.6M |
| 总资产 | $216.3M | $454.1M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISEMR
| Q4 25 | $97.5M | $264.3M | ||
| Q3 25 | $94.4M | $80.8M | ||
| Q2 25 | $96.0M | $54.3M | ||
| Q1 25 | $93.2M | $64.7M | ||
| Q4 24 | $101.0M | $48.9M | ||
| Q3 24 | $96.7M | $45.1M | ||
| Q2 24 | $96.8M | $69.6M | ||
| Q1 24 | $107.2M | $41.4M |
总债务PBYISEMR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISEMR
| Q4 25 | $130.3M | $288.6M | ||
| Q3 25 | $115.3M | $289.7M | ||
| Q2 25 | $104.7M | $279.0M | ||
| Q1 25 | $97.1M | $268.7M | ||
| Q4 24 | $92.1M | $256.6M | ||
| Q3 24 | $71.1M | $248.5M | ||
| Q2 24 | $48.5M | $235.6M | ||
| Q1 24 | $51.0M | $226.0M |
总资产PBYISEMR
| Q4 25 | $216.3M | $454.1M | ||
| Q3 25 | $202.9M | $450.4M | ||
| Q2 25 | $194.9M | $424.9M | ||
| Q1 25 | $196.2M | $416.5M | ||
| Q4 24 | $213.3M | $390.9M | ||
| Q3 24 | $220.7M | $383.8M | ||
| Q2 24 | $205.0M | $372.9M | ||
| Q1 24 | $214.1M | $341.7M |
负债/权益比PBYISEMR
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $14.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $14.8M |
| 自由现金流率自由现金流/营收 | 19.1% | 12.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $57.8M |
8季度趋势，按日历期对齐
经营现金流PBYISEMR
| Q4 25 | $14.4M | $14.9M | ||
| Q3 25 | $9.7M | $21.9M | ||
| Q2 25 | $14.1M | $684.0K | ||
| Q1 25 | $3.6M | $22.1M | ||
| Q4 24 | $15.6M | $11.9M | ||
| Q3 24 | $11.0M | $8.1M | ||
| Q2 24 | $1.0M | $12.1M | ||
| Q1 24 | $11.2M | $14.8M |
自由现金流PBYISEMR
| Q4 25 | $14.4M | $14.8M | ||
| Q3 25 | $9.7M | $21.5M | ||
| Q2 25 | $14.1M | $80.0K | ||
| Q1 25 | $3.6M | $21.4M | ||
| Q4 24 | $15.6M | $11.5M | ||
| Q3 24 | $11.0M | $7.6M | ||
| Q2 24 | $1.0M | $10.0M | ||
| Q1 24 | — | $14.0M |
自由现金流率PBYISEMR
| Q4 25 | 19.1% | 12.6% | ||
| Q3 25 | 17.7% | 19.2% | ||
| Q2 25 | 26.8% | 0.1% | ||
| Q1 25 | 7.7% | 20.4% | ||
| Q4 24 | 26.4% | 11.2% | ||
| Q3 24 | 13.7% | 7.8% | ||
| Q2 24 | 2.1% | 11.0% | ||
| Q1 24 | — | 16.3% |
资本支出强度PBYISEMR
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 2.4% | ||
| Q1 24 | 0.0% | 0.9% |
现金转化率PBYISEMR
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | 26.04× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 0.54× | 7.44× | ||
| Q2 24 | — | 7.32× | ||
| Q1 24 | — | 6.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
